Renascience

Renascience Interest Expense

The Interest Expense of Renascience (4889.T) as of Nov 19, 2026 is -304,000.00 JPY. In the previous year, Interest Expense was 418,000.00 JPY — a change of -172.73% (lower).

Interest Expense

-304,000.00JPY

YoY

-172.73%

Last updated:

Interest Expense of Renascience is 2025 -304,000.00 JPY. Interest Expense of Renascience was 2024 418,000.00 JPY. It decreases by -172.73% lower compared to the previous year.

The Renascience Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2020
-661,000.00 JPY
Jan 1, 2021
-6.36 M JPY
Jan 1, 2022
-5.44 M JPY
Jan 1, 2023
26,000.00 JPY
Jan 1, 2024
418,000.00 JPY
Jan 1, 2025
-304,000.00 JPY
The Renascience Interest Expense history
YEARInterest ExpenseYoY
-304,000.00JPY-172.73%
418,000.00JPY+1,507.69%
26,000.00JPY-100.48%
-5.44 MJPY-14.48%
-6.36 MJPY+862.33%
-661,000.00JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Renascience Stock analysis

What does Renascience do? Renascience, Inc. develops and sells pharmaceuticals, focusing on drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The company collaborates with physicians in research and development of pharmaceuticals, medical devices, and AI solutions for medical problems. Its products target aging-related health issues, including women's and children's diseases and solutions for COVID-19 infection. The firm's revenue comes from the sale of developed pharmaceuticals, medical devices, and AI solutions. Physicians and medical institutions are key buyers of its products, as the company's R&D is conducted in collaboration with them. The primary market segments are aging populations suffering from chronic conditions and healthcare providers seeking innovative medical solutions. Renascience, Inc. operates with a small team of three full-time employees, emphasizing focused R&D on specific medical challenges. Its business model centers on developing targeted therapies for high-impact diseases, leveraging partnerships with physicians to address unmet medical needs in aging-related health conditions. Renascience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renascience stock

Interest Expense of Renascience is -304,000.00 JPY in 2025.

Interest Expense of Renascience changed from 418,000.00 JPY to -304,000.00 JPY, representing a -172.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Renascience since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Renascience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Renascience

All Key Metrics — Renascience